Due Diligence Capabilities
Have confidence when preparing to enter into a potential legal agreement in the life sciences industry with deep experts who can help you assess the situation thoroughly.
01
Strategic Perspective
We offer a synthesis of strategic insight, experience, and a fact-based approach combined with our exposure to clients across the pharmaceutical, biotech, and device landscapes.
Start Getting More Done!
02
Deep Industry Experience
Kymanox does life sciences. Period. And that means you get well-rounded industry experts who will help you accurately understand the situation.
Start Getting More Done!
03
Good, Old-Fashioned Honesty
If you’re looking for a real honest analysis and recommendation and are willing to hear news that may contradict your intentions Kymanox is excited to partner with you on your project.
Start Getting More Done!
04
Not too big, not too small
Kymanox is a fast-growing company devoted to the life sciences industry. Our 100+ employees means we have a plethora of experience to leverage on your project but you won’t get lost in the shuffle found at larger firms.
Start Getting More Done!
Meet our Due Diligence Experts
Stephen M. Perry
CEO
Markets That Benefit from Our Due Diligence Solutions
Drug Combination Products
Our experts understand the interaction between devices and drug products. Our experience includes injectables, nasal, respiratory, and more.
Biologics and Cell & Gene Therapy Services
We understand why “the product is the process” and how to implement solutions to your unique challenges.
The Kymanox Due Diligence Difference
Our clients tell us traditional integrators simply do not fully understand the complexities of working in a highly regulated environment. The Kymanox team lives in regulatory environments every day so you’ll get practical solutions.
Proven Broad Expertise
Our team of experts is focused on life sciences with extensive experience across drug and device development. No matter your challenge, we can help you conquer it.
Flexibility & Agility
At Kymanox, we make it easy for clients to get the solutions they need, when they need it. Clients tell us our flexibility is one of the key reasons they keep coming back.
Relationship Focus
We are proud of the relationships we build with our clients. Many times, we are indistinguishable from client employees on projects. It’s one reason our first client, and many others, are still clients today.
Frequently Asked Due Dilligence Questions (FAQs)
What is due diligence?
Due diligence is an investigation, audit, or review performed to confirm facts or details of a matter under consideration. In the financial world, due diligence requires an examination of financial records before entering into a proposed transaction with another party. (Source: investopedia.com)
What does due diligence typically cover?
Information should cover all aspects of a business and typically cover most, if not all, of the following categories. Please note this list is not exhaustive but is designed to provide perspective on the breadth of information involved.
- Company information including structure, ownership details, competitors, suppliers, recent annual reports
- Financial information including balance sheets, income statements, tax returns, and credit reports.
- Product & Service offering which includes details on all items the company sells along with associated specific details on costs, margins, historical sales, and forecast. Included with this should be any details on new products/services that are in development.
- Customer information including prior sales by customer in addition to names of companies and contact information, where applicable.
- Employee & freelancer/contractor information
- Intellectual property including patents, copyrights, trademarks, etc.
- Legal landscape including applicable laws and regulations, prior litigation, applicable permitting/licensing, and insurance policies.
Read the Latest at Kymanox
Kymanox Named as Winner of 2022 Triangle Business Journal Fast 50 Award
Triangle Business Journal held awards ceremony on Wednesday, 09 November 2022
Monday, 21 November 2022
Research Triangle Park, North Carolina, USA
Kymanox Corporation (“Kymanox”), a professional services company exclusively serving the ...
Becoming a Gemstone: Full AAV Capsid Separation and Final AAV Product
In the past two blog posts we discussed adeno-associated viruses (AAVs) and their purification. In our final post on AAVs, we are focusing on methods for full capsid separation, the final step in obtaining viral particles of sufficient quality for ...
The Path from Lump of Coal to Gemstone: Challenges with AAV Purification
Last time we discussed Adeno-Associated Viruses (AAVs) as tools for gene therapy as well as the first steps in AAV preparation via the determination of the full to empty capsid ratio. Today, we will dive deeper into the process of AAV purification....